PREZISTA 100 mg/ml, oral suspension bottle, 200 ml
Active ingredients: Darunavir, Darunavir ethanolate
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PREZISTA 100 mg/ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 200 ml avec pipette(s) doseuse(s)
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Oct 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64478874CIP72670495CIP133400926704957Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DARUNAVIRsuspension | 100 mg · 1 ml de suspension | FT |
| ÉTHANOLATE DE DARUNAVIRsuspension | 108,40 mg · 1 ml de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.